INTRODUCTION
============

Primary headache (PH) and chronic orofacial pain are common symptoms in the general population[@B08], and the presence of headache in patients reporting temporomandibular disorders (TMD) have a high prevalence of 50 to 80%[@B06] ^,^ [@B08] ^,^ [@B28], whereas these numbers in patients without TMD are only 13 to 23%[@B19] ^,^ [@B33].

Primary headache individuals could experience more severe and frequent symptoms of TMD, and vice-versa[@B02] ^,^ [@B03]. The relationship between these two entities, however, is not well established in the literature yet[@B05] ^,^ [@B19].

Some studies have shown that TMD therapy reduces the complaint of headache in both intensity and frequency[@B30], nevertheless, to the best of our knowledge, the impact of PH on TMD therapy efficacy has not been published yet.

Furthermore, some studies have confirmed that the presence of parafunctional habits, i.e., activities of the masticatory muscles, as clenching and grinding, has an important role in TMD pain, whereas patients with sleep bruxism have an increased risk for the occurrence of myofascial pain[@B15]. This association with headache is not well defined[@B29].

Based on the above, this study aimed to evaluate the influence of the presence of PH on the efficacy of a TMD conservative therapy and the association with the presence of self-reported parafunctional habits. The null hypothesis is that the presence of primary headaches does not influence negatively the efficacy of TMD management.

SAMPLE AND METHODS
==================

This study was approved by the Institutional Ethics Committee, under protocol \#105/2010.

Sample
------

This cross-sectional study performed 1,200 evaluations in medical records from an Orofacial Pain Clinic, from 1996 to 2009. The sample was composed of 400 medical records, initially selected according to the following criteria:

Inclusion:

1\. Medical records of adults aged 18 years or more with:

2\. Presence of myofascial pain with or without the presence of muscular trigger points by manual palpation, according to the American Academy of Orofacial Pain (AAOP)[@B11];

Exclusion:

1\. Medical records of individuals with neurological diseases, fibromyalgia, systemic arthritis, secondary headache or paroxysmal hemicrania, menstrual and cluster headache.

Group establishment
-------------------

After fulfilling the initial criteria, the medical records were analyzed according to the presence or not of TMD through AAOP criteria[@B11]; and PH based on International Headache Society (IHS)[@B24], fulfilling the criteria for migraine and/or tensiontype headache.

Patients could be allocated into one of the four groups below:

### I) Only muscular TMD (with no headache complaint):

This group was composed of 64 medical records of subjects with muscular TMD only. Muscular TMD encompassed localized myalgia and masticatory myofascial pain according to AAOP[@B11].

They had undergone a conservative therapy for three months with a rigid acrylic upper full coverage stabilization appliance, along with counseling for habits and behavioral changes, home care instructions, exercises and Physical therapy modalities[@B09]. Analgesics and anti-inflammatory drugs could also be used.

### II) Muscular TMD+primary headache:

This group was composed of 48 medical records of subjects with muscular TMD plus the presence of primary headache. They had undergone the same conservative therapy for group I, with no specific headache management.

### III) Only muscular TMD+articular TMD (with no headache complaint):

This group was composed of 173 medical records from subjects with muscular and articular TMD. They had undergone the same conservative therapy for group I.

Articular TMD included arthralgia and disc displacement with or without reduction, with or without mouth opening limitation, fulfilling the AAOP criteria[@B11].

### IV) Muscular TMD+articular TMD+primary headache:

This group was composed of 115 medical records of subjects with muscular and articular TMD plus the presence of primary headache. They had undergone the same conservative therapy for group I, with no specific headache management.

Examiners and variables
-----------------------

Two examiners performed all the medical records evaluations. Current pain intensity was analyzed according to self-reported pain on Visual Analogue Scale (VAS) at baseline and after three months of TMD therapy. Moreover, the existence or not of selfreported clenching/bruxism parafunctional habits was analyzed at baseline. The pain experience duration, in months, was also recorded.

Data analysis
-------------

The results were analyzed with repeated measurements ANOVA (after Kolmogorov-Smirnov to test normal distribution) to assess within and between groups differences; Chi-Square test followed by Odds Ratio test, with 95% of Confidence Interval (CI), to test association between PH and bruxism; and Spearman Correlation to correlate pain duration and pain intensity variation between baseline and after therapy. The results were established with a significance level of 5%.

RESULTS
=======

The mean age was 36.87 years for group I, 36.79 years for group II, 36.36 for group III, and 36.79 for group IV (p=0.55). Women were 81.25% of group I, 89.58%, 86.12%, and 94.78% of group II, III, and IV, respectively.

In the within groups analysis, there was a significant reduction in the reported pain for all groups (p\<0.05) after three months of TMD therapy ([Figure 1](#f01){ref-type="fig"}).
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Pain improvement in VAS was 70.74% (SD 30.71) and 46.32% (SD 24.70) for group I and II, respectively, and 66.44% (SD 35.37) and 42.56% (SD 31.72) for group III and IV, respectively ([Figure 1](#f01){ref-type="fig"}). Significant results revealed better pain improvement for group I compared to group II, and for group III, when compared to group IV (p\<0.05%) ([Figure 1](#f01){ref-type="fig"}).

At baseline, significant differences for the self-report of clenching/bruxism were perceived only between groups I and II with III and IV, which showed that subjects with muscular TMD had at baseline a higher percentage of clenching/bruxism parafunctional habits than subjects with muscular and articular TMD, without considering the presence or not of PH ([Table 1](#t1){ref-type="table"}). No differences were found on the association between PH and bruxism ([Table 2](#t2){ref-type="table"}).

###### Percentage of clenching/bruxism parafunctional habits between groups

  GROUP   TOTAL   PRESENCE OF CLENCHING/BRUXISM   PERCENTAGE
  ------- ------- ------------------------------- ------------
  I       64      57                              89.06%^a^
  II      48      42                              87.50%^a^
  III     173     86                              49.71%^b^
  IV      115     59                              51.30%^b^

indicates no between-groups differences (p\>0.05)

indicates between-groups differences (p\<0.05)

###### Chi-Square test (X2) and Odds Ratio (OR) of association between primary headache and clenching/bruxism parafunctional habits

                    HEADACHE      WITHOUT HEADACHE   TOTAL
  ----------------- ------------- ------------------ -------
  BRUXISM           101 (41.4%)   143 (58.6%)        244
  WITHOUT BRUXISM   62 (39.7%)    94 (60.3%)         156
  TOTAL             163           237                400

p=0.743, OR=1.07 (0.71-1.61)

The mean duration of pain experience was 63.71 months (SD 62.37), 70.95 (SD 76.85), 58.91 (SD 71.00), and 67.92 (SD 84.38) for group I, II, III, and IV, respectively (p=0.10). No significant correlation with the pain improvement was detected (Spearman R=0.036, p=0.39).

DISCUSSION
==========

This study evaluated 400 medical records regarding the efficacy of TMD management in patients with primary headache as a comorbid condition. The null hypothesis was rejected. The main findings were: (1) a conservative therapy with stabilization appliance and counseling for habits and behavioral changes was effective in the TMD pain relief; (2) the presence of concomitant primary headache negatively influenced the efficacy of TMD therapy; (3) no association between the presence of self-reported bruxism and PH was found; and (4) no correlation was found between TMD management efficacy on pain severity and the duration of pain experience.

Our sample was mainly composed of women (88%), aged between 30-45 years (35.47±12.59), which is in agreement with epidemiological publications[@B17] ^,^ [@B27]. All groups had chronic craniofacial pain, with mean duration of 63.72±74.30 months.

After three months of therapy, management strategies as stabilization splint and counseling for behavioral changes used in the present study provided a significant improvement in the pain levels of articular and/or muscular TMD when judged by the VAS. This management approach is supported by the literature and is recommended as an effective therapy modality[@B07] ^,^ [@B16] ^,^ [@B17] ^,^ [@B21] ^,^ [@B22] ^,^ [@B32].

A possible explanation on the use of this management approach is based on a decrease of the overload masticatory system[@B02] ^,^ [@B23]. Stabilization splints provide proper occlusal relationship, reduction in muscular activity, stable physiologic mandibular posture; and with the potential cognitive and placebo effect[@B20] ^,^ [@B31]. The actual results may have an essential correlation with all these mechanisms of action. Furthermore, the patient education about behavioral changes, the probable high impact of the patient\'s initial reaction to a professional orientation, and also placebo effect, natural evolution of the disease and regression towards the mean[@B09] may play a role in the pain reduction for all groups observed in this study.

After the TMD management, groups with additional diagnosis of primary headache did not have the same level of amelioration than groups with only TMD and without PH. It has been very well established that nociceptive impulses arising from masticatory muscles and temporomandibular joint, as well as cranial tissues and head area, may induce central sensitization mechanisms in the subnucleus caudalis of the trigeminal nerve system[@B19]. Since both areas, TMD and head region, share similar ascendant pain pathways in the trigeminal system, the increase in pain transmission from peripheral tissues to the trigeminal system could explain the fact that the presence of comorbid PH, not treated, could influence negatively a TMD therapy, and the approach of both conditions should be stated.

The effectiveness of stabilization devices in the management of TMD pain is well documented and it is related to the re-establishment of proper occlusal relationship; the reduction in muscular activity; the cognitive effect, since the patients became aware of their oral parafunctional habits; and the placebo effect[@B07] ^,^ [@B09] ^,^ [@B17] ^,^ [@B22] ^,^ [@B32]. However, the literature is vague about this fact in headache improvement. Some studies report headache pain decrease, in both intensity and frequency, about 30 to 50% when TMD was treated with splint therapy, in short and long-term evaluations[@B12] ^,^ [@B13] ^,^ [@B30].

The literature suggests that subjects with sleep bruxism have increased risk for myofascial and joint pain conditions[@B15]. In this study, the prevalence of clenching/bruxism parafunctional habits was very high for all groups.

Some studies had showed that the postexercise muscle soreness is associated with this overload mechanism of muscle pain in individuals with bruxism, which can be a risk factor to the installation of myofascial TMD[@B03] ^,^ [@B10] ^,^ [@B15]. Our results show higher prevalence of bruxism in the muscular TMD groups only, and lower values in the articular TMD groups. It is possible that this outcome could be a result of a difference in the pathophysiology between the articular and the muscular TMD. In the group presenting with articular and muscular TMD, the muscle pain might be a consequence of the articular pain conditions, which, in turn, could lead to a muscle co-contraction. In this case, the occurrence of parafunctional habits could not be as important as in the case of only muscle pain. Furthermore, the prevalence of bruxism in articular TMD patients is lower[@B25]. Finally, considering that muscle pain could be a symptom of bruxism[@B04], in the group of only muscular TMD, bruxism could be the primary source of pain, which explains the higher prevalence in the groups I and II.

The causal relationship between bruxism and TMD is controversial. A recent systematic review found that studies based on self-report or clinical diagnosis of bruxism have a positive association with TMD, while studies based on more specific quantitative diagnostic methods revealed a weak association with symptoms of TMD[@B26]. Although parafunctional habits increase the activation of masticatory muscles[@B18], which sometimes may cause pain[@B01], bruxism is not always correlated with the pain caused by TMD. In this sense, to establish a direct causal relationship between bruxism and TMD is difficult.

Our study showed that self-reported bruxism was not associated with the presence of PH. A recent study evaluated the association between TMD, sleep bruxism (SB) and PH. It could be found that in patients with painful TMD and SB, only the presence of sleep bruxism did not increase the risk for any kind of PH[@B14].

No correlation between TMD improvement after three months and duration of pain experience was found. It was expected that the longer the pain experience, the higher the peripheral and central sensitization, associated to some sort of impairment of the descending inhibitory analgesic system, which could influence the efficacy of pain management. However, this fact was not tested here. The non-administration of central acting medication and strategies devoted to revert such central alterations could explain this similarity between those with more time of pain experience and those with less time.

Another limitation of the present study is the relatively weak reliability of the data obtained from the medical records, usually handled by different professionals. Although extracted from records from the same treatment center, variations in diagnosis and management strategies are expected, jeopardizing the present results.

Based on the aforementioned, this study showed the potential and significant effect that headache has in the efficacy of TMD management. A combined approach to both pain conditions is suggested.
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